1. Lahera V, Salom MG, Fiksen-Olsen MJ, Raij L, Romero JC. Effects of NG-monomethyl-L-arginine and L-arginine on acetylcholine response. Hypertension. 1990. 15:659–663.
2. Kashgarian M, Biemesderfer D, Caplan M, Forbush B 3rd. Monoclonal antibody to Na, K-ATPase: immunocytochemical localization along nephron segments. Kidney Int. 1985. 28:899–913.
3. Amemiya M, Loffing J, Lotscher M, Kaissling B, Alpern RJ, Moe OW. Expression of NHE-3 in the apical membrane of rat renal proximal tubule and thick ascending limb. Kidney Int. 1995. 48:1206–1215.
Article
4. Gamba G, Miyanoshita A, Lombardi M, Lytton J, Lee WS, Hediger MA, Hebert SC. Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney. J Biol Chem. 1994. 269:17713–17722.
Article
5. Knepper MA, Kim GH, Fernandez Llama P, Ecelbarger C. Regulation of thick ascending limb transport by vasopressin. J Am Soc Nephrol. 1999. 10:628–634.
Article
6. Roczniak A, Burns KD. Nitric oxide stimulates guanylate cyclase and regulates sodium transport in rabbit proximal tubule. Am J Physiol. 1996. 270:F106–F115.
Article
7. McKee M, Scavone C, Nathanson JA. Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proc Natl Acad Sci USA. 1994. 91:12056–12060.
Article
8. Varela M, Herrera M, Garvin JL. Inhibition of Na-K-ATPase in thick ascending limbs by NO depends on O2 - and is diminished by a high-salt diet. Am J Physiol Renal Physiol. 2004. 287:F224–F230.
9. Ortiz PA, Hong NJ, Garvin JL. NO decreases thick ascending limb chloride absorption by reducing Na+-K+-2Cl- cotransporter activity. Am J Physiol Renal Physiol. 2001. 281:F819–F825.
10. Nakanishi K, Hara N, Nagai Y. Salt-sensitive hypertension in conscious rats induced by chronic nitric oxide blockade. Am J Hypertens. 2002. 15:150–156.
Article
11. Salazar FJ, Alberola A, Pinilla JM, Romero JC, Quesada T. Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension. 1993. 22:49–55.
Article
12. Nakanishi K, Mattson DL, Cowley AW Jr. Role of renal medullary blood flow in the development of L-NAME hypertension in rats. Am J Physiol. 1995. 268:R317–R323.
Article
13. Norby JG. Coupled assay of Na+,K+-ATPase activity. Methods Enzymol. 1988. 156:116–119.
14. Lee J, Choi KC, Yeum CH, Kim W, Yoo K, Park JW, Yoon PJ. Impairment of endothelium-dependent vasorelaxation in chronic two-kidney, one clip hypertensive rats. Nephrol Dial Transplant. 1995. 10:619–623.
15. Kang DG, Kim JW, Lee J. Effects of nitric oxide synthesis inhibition on the Na,K-ATPase activity in the kidney. Pharmacol Res. 2000. 41:123–127.
Article
16. Roczniak A, Burns KD. Nitric oxide stimulates guanylate cyclase and regulates sodium transport in rabbit proximal tubule. Am J Physiol. 1996. 270:F106–F115.
Article
17. Stoos BA, Garvin JL. Actions of nitric oxide on renal epithelial transport. Clin Exp Pharmacol Physiol. 1997. 24:591–594.
Article
18. Plato CF, Stoos BA, Wang D, Garvin JL. Endogenous nitric oxide inhibits chloride transport in the thick ascending limb. Am J Physiol. 1999. 276:F159–F163.
19. Ortiz PA, Hong NJ, Garvin JL. NO decreases thick ascending limb chloride absorption by reducing Na+-K+-2Cl- cotransporter activity. Am J Physiol Renal Physiol. 2001. 281:F819–F825.
20. He H, Podymow T, Zimpelmann J, Burns KD. NO inhibits Na+-K+-2Cl- cotransport via a cytochrome P-450-dependent pathway in renal epithelial cells (MMDD1). Am J Physiol. 2003. 284:F1235–F1244.
21. Kim GH, Masilamani S, Turner R, Mitchell C, Wade JB, Knepper MA. The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein. Proc Natl Acad Sci USA. 1998. 95:14552–14557.
Article